Recent advances in the genetics of idiopathic pulmonary fibrosis

被引:8
|
作者
Spagnolo, Paolo [1 ,3 ]
Lee, Joyce S. [2 ]
机构
[1] Univ Padua, Dept Cardiac Thorac Vasc Sci & Publ Hlth, Resp Dis Unit, Padua, Italy
[2] Univ Colorado Denver, Anschutz Med Campus, Aurora, CO USA
[3] Univ Padua, Dept Cardiac Thorac Vasc Sci & Publ Hlth, Resp Dis Unit, Via Giustiniani 2, I-35128 Padua, Italy
关键词
genetics; idiopathic pulmonary fibrosis; mutations; pathogenesis; telomeres; RECEPTOR-3 L412F POLYMORPHISM; MUC5B PROMOTER POLYMORPHISM; ACUTE EXACERBATION; RISK-FACTOR; VARIANTS; SUSCEPTIBILITY; ASSOCIATION; CONTRIBUTE; RARE;
D O I
10.1097/MCP.0000000000000989
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Purpose of reviewGenetics contributes substantially to the susceptibility to idiopathic pulmonary fibrosis (IPF). Genetic studies in sporadic and familial disease have identified several IPF-associated variants, mainly in telomere-related and surfactant protein genes.Here, we review the most recent literature on genetics of IPF and discuss how it may contribute to disease pathogenesis.Recent findingsRecent studies implicate genes involved in telomere maintenance, host defence, cell growth, mammalian target of rapamycin signalling, cell-cell adhesion, regulation of TGF-& beta; signalling and spindle assembly as biological processes involved in the pathogenesis of IPF. Both common and rare genetic variants contribute to the overall risk of IPF; however, while common variants (i.e. polymorphisms) account for most of the heritability of sporadic disease, rare variants (i.e. mutations), mainly in telomere-related genes, are the main contributors to the heritability of familial disease. Genetic factors are likely to also influence disease behaviour and prognosis. Finally, recent data suggest that IPF shares genetic associations - and probably some pathogenetic mechanisms - with other fibrotic lung diseases.Common and rare genetic variants are associated with susceptibility and prognosis of IPF. However, many of the reported variants fall in noncoding regions of the genome and their relevance to disease pathobiology remains to be elucidated.
引用
收藏
页码:399 / 405
页数:7
相关论文
共 50 条
  • [1] Recent Advances in Idiopathic Pulmonary Fibrosis
    Park, Sanghoon
    Lee, Eun Joo
    TUBERCULOSIS AND RESPIRATORY DISEASES, 2013, 74 (01) : 1 - 6
  • [2] Recent advances in idiopathic pulmonary fibrosis
    Noth, Imre
    Martinez, Fernando J.
    CHEST, 2007, 132 (02) : 637 - 650
  • [3] Idiopathic pulmonary fibrosis: Recent advances on pharmacological therapy
    Spagnolo, P.
    Maher, T. M.
    Richeldi, L.
    PHARMACOLOGY & THERAPEUTICS, 2015, 152 : 18 - 27
  • [4] Genetics of Idiopathic Pulmonary Fibrosis
    Barros, Andrew
    Oldham, Justin
    Noth, Imre
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2019, 357 (05): : 379 - 383
  • [5] Molecular genetics of idiopathic pulmonary fibrosis
    Mustafin, R. N.
    VAVILOVSKII ZHURNAL GENETIKI I SELEKTSII, 2022, 26 (03): : 308 - 318
  • [6] Advances in the management of idiopathic pulmonary fibrosis and progressive pulmonary fibrosis
    Liu, Gabrielle Y.
    Budinger, G. R. Scott
    Dematte, Jane E.
    BMJ-BRITISH MEDICAL JOURNAL, 2022, 377
  • [7] Advances in understanding of idiopathic pulmonary fibrosis
    Wang Zeng-li
    CHINESE MEDICAL JOURNAL, 2009, 122 (07) : 844 - 857
  • [8] Therapeutic advances in idiopathic pulmonary fibrosis
    Fraser, Emily
    Hoyles, Rachel K.
    CLINICAL MEDICINE, 2016, 16 (01) : 42 - 51
  • [9] Therapeutic advances in idiopathic pulmonary fibrosis
    George, G.
    Vaid, U.
    Summer, R.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2016, 99 (01) : 30 - 32
  • [10] DIAGNOSTIC ADVANCES IN IDIOPATHIC PULMONARY FIBROSIS
    KING, TE
    CHEST, 1991, 100 (01) : 238 - 241